Biotechnology
Moderna Unveils Promising New Vaccine Candidates Beyond COVID
Breakthrough Clinical Trial Data Sets Stage for Diversified Product Portfolio Moderna (MRNA), the pioneering biotech company known for its COVID...
Viking Therapeutics’ Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials
Promising Results Propel Shares Higher as VK2735 Shows Potential for Significant Weight Reduction Viking Therapeutics' (VKTX) latest achievement in weight...
AbbVie to Acquire Landos Biopharma: Advancing Novel Oral Therapies for Autoimmune Diseases
AbbVie's Acquisition of Landos Marks a Strategic Move in Autoimmune Disease Treatment Development AbbVie Inc. (ABBV) has announced a definitive...
Yield10 Hits Regulatory Milestone for Omega-3 Camelina
USDA's Approval Signals Advancement in Land-Based Production of Essential Fatty Acids Yield10 Bioscience (YTEN) has achieved a significant regulatory milestone,...
XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction
Expanding Portfolio Strengthens XTL's Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has...
BioNTech Reports Revenue Plunge as Focus Shifts to Cancer Drugs
Shares Fall Over 9% as Biotech Giant Transitions Away from Pandemic-Era Vaccine Sales BioNTech (BNTX), the pioneering biotechnology firm behind...
AstraZeneca to Acquire Fusion Pharmaceuticals: Pioneering Precision Cancer Treatments
Acquisition Marks AstraZeneca's Commitment to Advancing Cancer Care with Radioconjugates AstraZeneca, (AZN) a leading global biopharmaceutical company, has announced a...
Ocular Therapeutix Announces Private Placement to Bolster Clinical Development Initiatives
Ocular Therapeutix, Inc. (OCUL), a pioneering biopharmaceutical company dedicated to advancing vision-related therapies, has disclosed its strategic move to enhance...
Monopar’s MNPR-101 Radiopharma Program Shows Promise in Targeting Advanced Cancers
Monopar Therapeutics (MNPR) has unveiled promising preclinical data for its MNPR-101 radiopharmaceutical program, marking a significant stride in the fight...
Moderna Reports Strong Spikevax Sales and Expands Vaccine Portfolio
Moderna Inc (MRNA) witnessed a surge in its stock following its fourth-quarter 2023 financial report, which showcased robust revenues of...
